These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

411 related items for PubMed ID: 30778048

  • 1. PBK, targeted by EVI1, promotes metastasis and confers cisplatin resistance through inducing autophagy in high-grade serous ovarian carcinoma.
    Ma H, Li Y, Wang X, Wu H, Qi G, Li R, Yang N, Gao M, Yan S, Yuan C, Kong B.
    Cell Death Dis; 2019 Feb 18; 10(3):166. PubMed ID: 30778048
    [Abstract] [Full Text] [Related]

  • 2. PBK promotes aggressive phenotypes of cervical cancer through ERK/c-Myc signaling pathway.
    Ma H, Han F, Yan X, Qi G, Li Y, Li R, Yan S, Yuan C, Song K, Kong B.
    J Cell Physiol; 2021 Apr 18; 236(4):2767-2781. PubMed ID: 33184870
    [Abstract] [Full Text] [Related]

  • 3. TTK inhibition increases cisplatin sensitivity in high-grade serous ovarian carcinoma through the mTOR/autophagy pathway.
    Qi G, Ma H, Li Y, Peng J, Chen J, Kong B.
    Cell Death Dis; 2021 Dec 07; 12(12):1135. PubMed ID: 34876569
    [Abstract] [Full Text] [Related]

  • 4. 4-Acetylantroquinonol B suppresses autophagic flux and improves cisplatin sensitivity in highly aggressive epithelial cancer through the PI3K/Akt/mTOR/p70S6K signaling pathway.
    Liu M, Bamodu OA, Huang WC, Zucha MA, Lin YK, Wu ATH, Huang CC, Lee WH, Yuan CC, Hsiao M, Deng L, Tzeng YM, Yeh CT.
    Toxicol Appl Pharmacol; 2017 Jun 15; 325():48-60. PubMed ID: 28408137
    [Abstract] [Full Text] [Related]

  • 5. PCNA-associated factor P15PAF , targeted by FOXM1, predicts poor prognosis in high-grade serous ovarian cancer patients.
    Jin C, Liu Z, Li Y, Bu H, Wang Y, Xu Y, Qiu C, Yan S, Yuan C, Li R, Diao N, Zhang Z, Wang X, Liu L, Kong B.
    Int J Cancer; 2018 Dec 01; 143(11):2973-2984. PubMed ID: 30129654
    [Abstract] [Full Text] [Related]

  • 6. ARHI (DIRAS3)-mediated autophagy-associated cell death enhances chemosensitivity to cisplatin in ovarian cancer cell lines and xenografts.
    Washington MN, Suh G, Orozco AF, Sutton MN, Yang H, Wang Y, Mao W, Millward S, Ornelas A, Atkinson N, Liao W, Bast RC, Lu Z.
    Cell Death Dis; 2015 Aug 06; 6(8):e1836. PubMed ID: 26247722
    [Abstract] [Full Text] [Related]

  • 7. SUSD2 promotes cancer metastasis and confers cisplatin resistance in high grade serous ovarian cancer.
    Xu Y, Miao C, Jin C, Qiu C, Li Y, Sun X, Gao M, Lu N, Kong B.
    Exp Cell Res; 2018 Feb 15; 363(2):160-170. PubMed ID: 29305171
    [Abstract] [Full Text] [Related]

  • 8. Hexokinase 2 confers resistance to cisplatin in ovarian cancer cells by enhancing cisplatin-induced autophagy.
    Zhang XY, Zhang M, Cong Q, Zhang MX, Zhang MY, Lu YY, Xu CJ.
    Int J Biochem Cell Biol; 2018 Feb 15; 95():9-16. PubMed ID: 29247711
    [Abstract] [Full Text] [Related]

  • 9. MicroRNA-625-3p improved proliferation and involved chemotherapy resistance via targeting PTEN in high grade ovarian serous carcinoma.
    Zhong L, Liu X, Wang L, Liu Y, Zhang D, Zhao Y.
    J Ovarian Res; 2022 Jan 14; 15(1):7. PubMed ID: 35027053
    [Abstract] [Full Text] [Related]

  • 10. EVI1 overexpression promotes ovarian cancer progression by regulating estrogen signaling.
    Wang Z, Li Y, Wang N, Li P, Kong B, Liu Z.
    Mol Cell Endocrinol; 2021 Aug 20; 534():111367. PubMed ID: 34146645
    [Abstract] [Full Text] [Related]

  • 11. Icariin enhances the chemosensitivity of cisplatin‑resistant ovarian cancer cells by suppressing autophagy via activation of the AKT/mTOR/ATG5 pathway.
    Jiang S, Chang H, Deng S, Fan D.
    Int J Oncol; 2019 Jun 20; 54(6):1933-1942. PubMed ID: 31081049
    [Abstract] [Full Text] [Related]

  • 12. Impact of iASPP on chemoresistance through PLK1 and autophagy in ovarian clear cell carcinoma.
    Chan KK, Wong OG, Wong ES, Chan KK, Ip PP, Tse KY, Cheung AN.
    Int J Cancer; 2018 Sep 15; 143(6):1456-1469. PubMed ID: 29663364
    [Abstract] [Full Text] [Related]

  • 13. PBK overexpression promotes metastasis of hepatocellular carcinoma via activating ETV4-uPAR signaling pathway.
    Yang QX, Zhong S, He L, Jia XJ, Tang H, Cheng ST, Ren JH, Yu HB, Zhou L, Zhou HZ, Ren F, Hu ZW, Gong R, Huang AL, Chen J.
    Cancer Lett; 2019 Jun 28; 452():90-102. PubMed ID: 30914208
    [Abstract] [Full Text] [Related]

  • 14. Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer.
    Wu H, Li R, Zhang Z, Jiang H, Ma H, Yuan C, Sun C, Li Y, Kong B.
    J Ovarian Res; 2019 Dec 29; 12(1):125. PubMed ID: 31884974
    [Abstract] [Full Text] [Related]

  • 15. Downregulation of ATG14 by EGR1-MIR152 sensitizes ovarian cancer cells to cisplatin-induced apoptosis by inhibiting cyto-protective autophagy.
    He J, Yu JJ, Xu Q, Wang L, Zheng JZ, Liu LZ, Jiang BH.
    Autophagy; 2015 Dec 29; 11(2):373-84. PubMed ID: 25650716
    [Abstract] [Full Text] [Related]

  • 16. Protein kinase C iota promotes glycolysis via PI3K/AKT/mTOR signalling in high grade serous ovarian cancer.
    Tyagi K, Roy A, Mandal S.
    Mol Biol Rep; 2024 Sep 14; 51(1):983. PubMed ID: 39276277
    [Abstract] [Full Text] [Related]

  • 17. CCNG1 (Cyclin G1) regulation by mutant-P53 via induction of Notch3 expression promotes high-grade serous ovarian cancer (HGSOC) tumorigenesis and progression.
    Xu Y, Zhang Q, Miao C, Dongol S, Li Y, Jin C, Dong R, Li Y, Yang X, Kong B.
    Cancer Med; 2019 Jan 14; 8(1):351-362. PubMed ID: 30565428
    [Abstract] [Full Text] [Related]

  • 18. ROR2 induces cell apoptosis via activating IRE1α/JNK/CHOP pathway in high-grade serous ovarian carcinoma in vitro and in vivo.
    Li R, Liu T, Shi J, Luan W, Wei X, Yu J, Mao H, Liu P.
    J Transl Med; 2019 Dec 26; 17(1):428. PubMed ID: 31878941
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of Autophagy Potentiated the Antitumor Effect of Nedaplatin in Cisplatin-Resistant Nasopharyngeal Carcinoma Cells.
    Liu Z, Liu J, Li L, Nie D, Tao Q, Wu J, Fan J, Lin C, Zhao S, Ju D.
    PLoS One; 2015 Dec 26; 10(8):e0135236. PubMed ID: 26288183
    [Abstract] [Full Text] [Related]

  • 20. Autophagy facilitates lung adenocarcinoma resistance to cisplatin treatment by activation of AMPK/mTOR signaling pathway.
    Wu T, Wang MC, Jing L, Liu ZY, Guo H, Liu Y, Bai YY, Cheng YZ, Nan KJ, Liang X.
    Drug Des Devel Ther; 2015 Dec 26; 9():6421-31. PubMed ID: 26715839
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.